Searches , social queries for BRISTOL MYERS-SQUIBB
Search references for BRISTOL MYERS-SQUIBB. Phrases containing BRISTOL MYERS-SQUIBB
See searches and references containing BRISTOL MYERS-SQUIBB!
Search references for BRISTOL MYERS-SQUIBB. Phrases containing BRISTOL MYERS-SQUIBB
See searches and references containing BRISTOL MYERS-SQUIBB!BRISTOL MYERS-SQUIBB
American pharmaceutical company
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New
Bristol_Myers_Squibb
Annual awards for scientific research (1977–2006)
Between 1977 and 2006, the Bristol-Myers Squibb Foundation presented annual awards of US$50,000 to scientists for distinguished achievements in fields
Bristol-Myers_Squibb_Awards
Children's Hospital in New Jersey, United States
The Bristol-Myers Squibb Children's Hospital at Robert Wood Johnson University Hospital (BMSCH) is a freestanding, 89-bed pediatric acute care children's
The Bristol-Myers Squibb Children's Hospital
The_Bristol-Myers_Squibb_Children's_Hospital
American businessman
as Bristol-Myers Squibb. Bristol-Myers Squibb is one of the largest pharmaceutical companies in the world. Myers' stepmother, Mary Ware Hewitt Myers (1848–1942)
John_Ripley_Myers
"Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023" (PDF). "Bristol Myers Squibb Q4 2022 Results" (PDF). "Bristol Myers
List of largest biomedical companies by revenue
List_of_largest_biomedical_companies_by_revenue
Pharmaceutical drug
myosin inhibitor. It was developed by MyoKardia, a subsidiary of Bristol Myers Squibb. In clinical studies, mavacamten has demonstrated significant efficacy
Mavacamten
Over-the-counter headache pain reliever
contains acetaminophen, aspirin and caffeine. It was manufactured by Bristol-Myers Squibb until it was purchased by Novartis in July 2005 along with other
Excedrin_(brand)
2017 United States Supreme Court case
Bristol-Myers Squibb Co. v. Superior Court of California, San Francisco County, 582 U.S. 255 (2017), was a United States Supreme Court case in which the
Bristol-Myers Squibb Co. v. Superior Court
Bristol-Myers_Squibb_Co._v._Superior_Court
American billionaire businessman
from 1978 to 1984. Martin was director of antiviral chemistry at Bristol-Myers Squibb from 1984 to 1990. Martin joined the American biotechnology company
John_C._Martin_(businessman)
Chemical compound
Admilparant is an investigational new drug being developed by Bristol-Myers Squibb for the treatment of idiopathic pulmonary fibrosis (IPF) and progressive
Admilparant
Biopharmaceutical company
growth was delayed by approximately 4.1 months. In September 2001, Bristol-Myers Squibb committed $2 billion (including a $1 billion up-front cash payment)
ImClone_Systems
Italian businessman (born 1950)
businessman. He is currently executive chairman of the board of Bristol Myers Squibb. Andreotti was born in Rome, Italy, in 1950, the son of Italian Senator
Lamberto_Andreotti
American pharmaceutical businessman (1819–1900)
pharmaceutics who founded E. R. Squibb and Sons, which eventually became part of the modern pharmaceutical giant Bristol-Myers Squibb. Squibb was born in Wilmington
E._R._Squibb
American businessman (1860–1935)
William McLaren Bristol (28 July 1860 – 1935) was one of the two co-founders of Bristol-Myers, now part of Bristol Myers Squibb. Myers and Bristol founded the
William_McLaren_Bristol
French artificial intelligence company
treatment. In June 2022, Owkin entered a strategic alliance with Bristol-Myers Squibb to help them design potentially more precise and efficient clinical
Owkin
Hospital in New Jersey, United States
transplantation, cancer care, and women's and children's care including The Bristol-Myers Squibb Children's Hospital at RWJUH, which has several areas of pediatric
Robert Wood Johnson University Hospital
Robert_Wood_Johnson_University_Hospital
Chemical compound
prevention of blood clots in patients undergoing surgery. In 2018–2023, Bristol-Myers Squibb studied milvexian for the prevention of stroke. Perera V, Wang Z
Milvexian
Israeli biotechnology company
equity investment agreement with Bristol-Myers Squibb. Under the terms of the agreement, Bristol Bristol-Myers Squibb will supply Opdivo®, its PD-1 inhibitor
Compugen_Ltd.
American biotechnology company
company that focuses on the development of cancer therapeutics. Bristol Myers Squibb acquired the company in January 2024. Mirati Therapeutics worked
Mirati_Therapeutics
Food and drink company of the United States, division of Reckitt
Mead Johnson & Company in 1905. The company was majority owned by Bristol-Myers Squibb after an acquisition in 1967, but was spun-off in 2009 as an independent
Mead_Johnson
American biopharmaceutical company
Delaware, headquartered in Summit, New Jersey, and a subsidiary of Bristol Myers Squibb (BMS) since its acquisition in 2019. Celgene was originally a unit
Celgene
Chemical compound
2 (TYK2) inhibitor and it is taken by mouth. It was developed by Bristol Myers Squibb. Deucravacitinib was approved for medical use in the United States
Deucravacitinib
Swedish-British pharmaceutical company
in cash to Bristol Myers Squibb, and Amylin being folded into an existing diabetes joint venture between AstraZeneca and Bristol Myers Squibb. In March
AstraZeneca
Chemical compound
class. Early development was solely by Bristol-Myers Squibb; in 2007 AstraZeneca joined with Bristol-Myers Squibb to co-develop the final compound and collaborate
Saxagliptin
Medication
Bristol-Myers Squibb Pharma EEIG. Repotrectinib was authorized for medical use in the European Union in January 2025. "Augtyro (Bristol-Myers Squibb Australia
Repotrectinib
Anticoagulant medication sold as Eliquis
medications. It is a direct factor Xa inhibitor. In 2007, Pfizer and Bristol-Myers Squibb began the development of apixaban as an anticoagulant. Apixaban was
Apixaban
Chemical compound
developed by collaboration of Bristol-Myers Squibb and Otsuka Pharmaceutical Co., Ltd, and named for Bristol-Myers Squibb research fellow Jagabandhu Das
Dasatinib
Antiplatelet medication
of a patent infringement case brought by Bristol-Myers Squibb. The court ruled that Bristol-Myers Squibb's patent was valid and provided protection until
Clopidogrel
Anticancer medication
April 2025, the FDA approved Nivolumab with Ipilimumab (Yervoy, Bristol Myers Squibb) for the treatment of adults and children aged 12 years and older
Nivolumab
American medical equipment company
healthcare providers enhance patient outcomes. 1989: Aspen Labs from Bristol-Myers Squibb 1995: New Dimensions in Medicine Inc. and the Birtcher Corporation
CONMED_Corporation
Diabetes medication
rare side effects include Fournier gangrene. It was developed by Bristol-Myers Squibb in partnership with AstraZeneca. It is on the World Health Organization's
Dapagliflozin
Pakistani pharmaceutical company
together. In December 2008, GSK Pakistan acquired operations of Bristol Myers Squibb in Pakistan for approximately US$36.5 million. In December 2010,
GSK_Pakistan
Former biotechnology company
Eastlake Avenue East. It was closed in 2019 after its acquisition by Bristol Myers Squibb. The company was founded in 1981 by Professors Earl W. Davie and
ZymoGenetics
American pharmaceutical company
for 8,000 products. The company's major customers include Bayer, Bristol-Myers Squibb, GlaxoSmithKline, Haleon, Novo Nordisk, Moderna, Pfizer, and Sarepta
Catalent
Chemical compound
azaepothilone B, codenamed BMS-247550) is a pharmaceutical drug developed by Bristol-Myers Squibb as a chemotherapeutic medication for cancer. Ixabepilone is a semi-synthetic
Ixabepilone
Medication
placebo group. The FDA granted the approval of xanomeline/tropsium to Bristol-Myers Squibb, which acquired Karuna Therapeutics during the FDA review in March
Xanomeline/trospium_chloride
Pharmaceutical compound
by Bristol Myers Squibb for eosinophilic esophagitis and atopic dermatitis. "Pharmaceutical Research & Development Pipeline - Bristol Myers Squibb". www
Cendakimab
Medication used for cancer
Bristol-Myers Squibb, The development of TAXOL (paclitaxel), March 1997, as cited in Goodman & Walsh 2001, p. 2 Rogers R (6 March 2000). "Bristol-Myers
Paclitaxel
Gene therapy medication
designations. The FDA granted approval of Abecma to Celgene Corporation, a Bristol-Myers Squibb Company. Idecabtagene vicleucel is the international nonproprietary
Idecabtagene_vicleucel
Laboratory Braun – B. Braun Melsungen (Medical) Ltd Bristol-Myers Squibb – Bristol-Myers Squibb Pharmaceuticals Ltd Celltech – UCB Pharma Ltd Cephalon
List of pharmaceutical manufacturers in the United Kingdom
List_of_pharmaceutical_manufacturers_in_the_United_Kingdom
Chemical compound
and secondary primary malignancies. Iberdomide was developed by Bristol Myers Squibb and has a higher binding affinity than lenalidomide or pomalidomide
Iberdomide
South Korean biotechnology company
companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol-Myers Squibb. Founded in 2011, Samsung Biologics built four manufacturing plants
Samsung_Biologics
American businessman
1960 to his retirement in 1995, he was a senior executive at the Bristol-Myers Squibb Company. Gelb was born in New York City, graduated from Phillips
Richard_L._Gelb
Pharmaceutical company
enhancing the body's innate immune response to cancer was purchased by Bristol-Myers Squibb, which set up a new company from this purchase and recruited IFM's
IFM_Therapeutics
American brand of hair care products
chief executive officer in 1972. Bristol-Myers merged with Squibb Corporation in 1989 to form Bristol-Myers Squibb, and Richard Gelb continued as CEO
Clairol
American pharmaceutical company
single tablet regimen for HIV, combining Sustiva (efavirenz), a Bristol-Myers Squibb product, and Truvada (emtricitabine and tenofovir disoproxil), a
Gilead_Sciences
American pharmaceutical company
Engineering Inc. for up to $156 million. In November 2017, Celgene, now Bristol-Myers Squibb (BMS), announced a collaboration with bluebird bio regarding bb2121
Genetix_Biotherapeutics
philanthropist. He is noted for incorporating and significantly expanding Bristol-Myers Squibb. He is also recognized for his charitable contributions to New York’s
Lowell_M._Palmer
Antihypertensive drug of the ACE inhibitor class
drug company E.R. Squibb & Sons Pharmaceuticals (now Bristol-Myers Squibb): Miguel Ondetti, Bernard Rubin, and David Cushman. Squibb filed for U.S. patent
Captopril
Japanese molecular biologist
Molecular Biology (1999) Jacobæus Prize, Novo Nordisk Foundation (2001) Bristol-Myers Squibb Award for Distinguished Achievement in Cardiovascular Research (2003)
Masashi_Yanagisawa
American biopharmaceutical company
Milpitas and Sunnyvale, California. In 2009, Medarex was purchased by Bristol Myers Squibb. Medarex developed monoclonal antibodies to CTLA-4 and PD-1, which
Medarex
American businessman
companies. Previously, he was a member of the executive committee of Bristol-Myers Squibb (NYSE:BMY), where he had global responsibilities for strategy, alliances
Jeremy_Levin
Chemical compound
Mezigdomide is a cereblon E3 ligase modulator developed by Bristol Myers Squibb to treat multiple myeloma. Richardson, Paul G.; Trudel, Suzanne; Quach
Mezigdomide
American biotechnology company
called cabozantinib) and another cancer candidate, XL-281, with Bristol Myers Squibb; BMS returned the rights to XL-184 to Exelixis in 2010 and returned
Exelixis
Cardiac myosin inhibitor developed by Bristol Myers Squibb
MYK-224) is a small-molecule cardiac myosin inhibitor developed by Bristol Myers Squibb for hypertrophic cardiomyopathy. Lehman, Sarah J.; Crocini, Claudia;
Delocamten
Marketing". justice.gov. 27 April 2010. Retrieved 25 August 2012. "Bristol-Myers Squibb to Pay More Than $515 Million to Resolve Allegations of Illegal Drug
List of largest pharmaceutical settlements
List_of_largest_pharmaceutical_settlements
Chemical compound
Danicamtiv is a cardiac myosin activator developed by Bristol Myers Squibb to treat dilated cardiomyopathy. Choi, Joohee; Holmes, Joshua B.; Campbell,
Danicamtiv
Chemical compound
Bristol-Myers Squibb to health care providers indicating action taken with the FDA to strengthen warnings for the medication. Subsequently, Bristol-Myers
Gatifloxacin
Form of cancer immunotherapy
antibody nivolumab (under the brand name Opdivo and developed by Bristol-Myers Squibb) were published in 2010. It was approved in 2014. Nivolumab is approved
Checkpoint_inhibitor
Pharmaceutical drug
diphenhydramine, ranitidine and acetaminophen. It is being developed by Bristol Myers Squibb and AbbVie. Common side effects of elotuzumab with lenalidomide and
Elotuzumab
Fourth-generation Cephalosporin Antibiotic
found no mortality difference. Cefepime was patented in 1982 by Bristol-Myers Squibb and approved for medical use in 1994. It is available as a generic
Cefepime
Diversity recruitment company
board search services to Fortune 1000 clients including Chanel, UBS, Bristol Myers Squibb, Intuit, EBay, Nike, Inc., and Amazon (company). In 2014, Mogul was
Mogul_(company)
Pakistani pharmaceutical company founded 1995
million deal, Martin Dow acquired the Laboratoires Salem (before 2010 Bristol-Myers Squibb) pharmaceutical manufacturing facility in Meymac, France. In March
Martin_Dow
Chemical compound
Daklinza is being withdrawn by Bristol Myers Squibb in countries where the drug is not typically prescribed, and Bristol Myers Squibb says it will not enforce
Daclatasvir
American toiletries brand specializing in hair care products
to 2003 the brand was owned by Bristol-Myers Squibb, an American Pharma and consumer goods company. Bristol-Myers Squibb had purchased the brand from the
Aussie_(shampoo)
American businessman
former parent company Altria Group. Lacy has served as a director of Bristol-Myers Squibb Company, Fidelity Funds (trustee), The Western Union Company, Sears
Alan_J._Lacy
American chemist and businessman (1898–1980)
Gelb, have each held executive positions at pharmaceutical company Bristol-Myers Squibb, which purchased Clairol in 1957. His legacy, the Lawrence M. Gelb
Lawrence_M._Gelb
Japanese pharmaceutical company
Prize later in 2018, is marketed by both Ono Pharmaceutical and Bristol-Myers Squibb. In 2024, Harvard University and Ono Pharmaceutical (ONO) entered
Ono_Pharmaceutical
Brand of moisturising lotion
Westwood Pharmaceutical of Buffalo, New York. It was later purchased by Bristol-Myers Squibb. Keri Lotion was first introduced by Westwood Pharmaceuticals to
Keri_Lotion
Immunomodulating pharmaceutical drug
signal, the T cell can't be activated. Abatacept was developed by Bristol-Myers Squibb and is licensed in the United States for the treatment of rheumatoid
Abatacept
illegal pricing and marketing practices for several of its drugs, Bristol-Myers Squibb paid out approximately $50 million to settle seven qui tam suits
List of off-label promotion pharmaceutical settlements
List_of_off-label_promotion_pharmaceutical_settlements
Chemical compound
to Bristol-Myers Squibb for development in certain countries, including the United States. On November 23, 2007, Pierre Fabre Medicament and Bristol-Myers
Vinflunine
Combination drug
treatment of melanoma. The applicant for this medicinal product is Bristol-Myers Squibb Pharma EEIG. Opdualag was approved for medical use in the European
Nivolumab/relatlimab
French pharmaceutical group
pharmaceutical group, independent from 1935 until acquisition by Bristol Myers Squibb in 1994. The company is now owned by Taisho Pharmaceutical. It was
Union de Pharmacologie Scientifique Appliquée
Union_de_Pharmacologie_Scientifique_Appliquée
Liquid injection device
the pharmaceutical manufacturer E.R. Squibb & Sons (eventually merged into the current day Bristol-Myers Squibb) just prior to World War II (WWII). In
Syrette
Anti-tumour drug
BMS-202 is a small-molecule drug PD-L1 inhibitor developed by Bristol-Myers Squibb which displays significant anti-tumor activity against glioblastoma
BMS-202
Town in Merseyside, England
the factory located next to the Burton's factory. Until the 1990s, Bristol-Myers Squibb was also a major employer to the local workforce, with a large factory
Moreton,_Merseyside
American businessman and diplomat (1933–2024)
an American businessman and diplomat, who was Chairman and CEO of Bristol-Myers Squibb Company, and as U.S. Ambassador to Sweden. His son is American musician
Charles_A._Heimbold_Jr.
Pharmaceutical drug
anti-CTLA4 was initiated by Medarex, which was later acquired by Bristol-Myers Squibb. For his work in developing ipilimumab, Allison was awarded the Lasker
Ipilimumab
Discovery-phase pharmaceutical company
Juno was later acquired by Celgene, which was in turn acquired by Bristol Myers Squibb. The company announced in 2015 that it was planning a clinical trial
Editas_Medicine
Chemical company
Pfizer Inc., Merck & Co., Eli Lilly and Company, Takeda, Genentech, Bristol-Myers Squibb Co. and GE. Founded in 1991 as Albany Molecular Research, Inc. (AMRI)
Curia_(company)
American chemical company
the company. In 1965, the Drackett family sold the business to Bristol-Myers. Bristol-Myers at that time included a variety of high-margin businesses such
Drackett
Ingelheim BIIB – Biogen BMS – Bristol-Myers Squibb BMY – Bristol-Myers Co., merging in 1989 into Bristol-Myers Squibb BRL – Beecham Research Labs, merged
List of pharmaceutical compound number prefixes
List_of_pharmaceutical_compound_number_prefixes
Brand of hard-surface cleaners
manufactured by S. C. Johnson & Son, since their purchase of Drackett from Bristol Myers Squibb in October 1992. The original product—an aerosol oven cleaner—was
Mr_Muscle
History of components of the S&P 500
to form ViacomCBS. November 21, 2019 NOW ServiceNow CELG Celgene Bristol-Myers Squibb acquired Celgene. October 3, 2019 LVS Las Vegas Sands NKTR Nektar
Historical components of the S&P 500
Historical_components_of_the_S&P_500
French multinational pharmaceutical and healthcare company
for hypertension, marketed by Bristol-Myers Squibb. Avapro (Irbesartan), for hypertension, marketed by Bristol-Myers Squibb. Cardizem (Diltiazem), for hypertension
Sanofi
2005 awards ceremony
September 2005. The National Television Academy announced the winners at Bristol-Myers Squibb in Princeton, New Jersey. For slow-motion color recording and playback
57th Technology and Engineering Emmy Awards
57th_Technology_and_Engineering_Emmy_Awards
Surname list
1993), Australian field hockey player Bristol Myers Squibb, pharmaceutical company Squib (disambiguation) Squibb Wilson (1913–1986), American football
Squibb
Brazilian engineer (born 1972)
Boston Consulting Group (BCG), Project Management Institute (PMI), Bristol-Myers Squibb, Saudi Telecom Company, Lee Hecht Harrison, NetEase and Agile Alliance
Ricardo_Viana_Vargas
Cholesterol lowering medication in the statin class
It is being marketed outside Japan by the pharmaceutical company Bristol-Myers Squibb. In 2005, Pravachol was the 22nd-highest selling brand-name drug
Pravastatin
British former politician (born 1970)
resumed his lobbying career when he joined pharmaceutical company Bristol Myers Squibb as their UK government relations director, eventually being promoted
Owen_Smith
Cancer drug
were $848 million, 31 percent year-over-year increase. In 2019 Bristol Meyers Squibb acquired Celgene for $74 billion dollars, and thus acquired Abraxis
Protein-bound_paclitaxel
Class of medications
Agonist for the Treatment of Schizophrenia in Adults" (Press release). Bristol Myers Squibb. 27 September 2024. Retrieved 27 September 2024 – via Business Wire
Antipsychotic
American businessman
September 2000, and senior vice president of Bristol-Myers Squibb and president of Bristol-Myers Squibb Worldwide Beauty Care from 1996 to January 2002
Stephen_Sadove
American alternative investment company
International Becton Dickinson Bio-Techne Biogen Boston Scientific Bristol Myers Squibb Cardinal Health Cencora Centene Corporation Charles River Laboratories
Blackstone_Inc.
Pharmaceutical drug
KGaA. A separate agreement grants co-exclusive rights among Merck, Bristol-Myers Squibb and Eli Lilly in Japan and expires in 2032. Cetuximab is given by
Cetuximab
Biopharmaceutical company
field-based sales personnel into Bristol-Myers Squibb operations. In December 2013, AstraZeneca purchased the Bristol-Myers Squibb share of the diabetes joint
Amylin_Pharmaceuticals
Monoclonal antibody
activation gene-3 (LAG-3) inhibitor. It is under development by Bristol-Myers Squibb. It is made using Chinese hamster ovary cells. In 2004, Drew Pardoll
Relatlimab
Chemical compound
multiforme trials. Lomustine was manufactured in limited supply by Bristol-Myers Squibb prior to 2013. This resulted in a short supply of a key chemotherapeutic
Lomustine
American multinational software company
International Becton Dickinson Bio-Techne Biogen Boston Scientific Bristol Myers Squibb Cardinal Health Cencora Centene Corporation Charles River Laboratories
Adobe_Inc.
travel, tourism, insurance
BRISTOL MYERS-SQUIBB
BRISTOL MYERS-SQUIBB
BRISTOL MYERS-SQUIBB
BRISTOL MYERS-SQUIBB
BRISTOL MYERS-SQUIBB
BRISTOL MYERS-SQUIBB
BRISTOL MYERS-SQUIBB
BRISTOL MYERS-SQUIBB
BRISTOL MYERS-SQUIBB
travel, tourism, insurance